Todd Asset Management LLC Trims Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Todd Asset Management LLC reduced its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 18.0% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 46,617 shares of the healthcare conglomerate’s stock after selling 10,199 shares during the quarter. Todd Asset Management LLC’s holdings in UnitedHealth Group were worth $24,416,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in UNH. Brighton Jones LLC lifted its stake in UnitedHealth Group by 176.2% during the fourth quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock worth $22,384,000 after purchasing an additional 28,231 shares during the last quarter. Revolve Wealth Partners LLC lifted its stake in UnitedHealth Group by 137.1% during the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock worth $2,033,000 after purchasing an additional 2,324 shares during the last quarter. Bank Pictet & Cie Europe AG lifted its stake in UnitedHealth Group by 3.9% during the fourth quarter. Bank Pictet & Cie Europe AG now owns 263,655 shares of the healthcare conglomerate’s stock worth $133,373,000 after purchasing an additional 9,872 shares during the last quarter. Sagespring Wealth Partners LLC bought a new position in UnitedHealth Group during the fourth quarter worth $8,860,000. Finally, TCM Advisors LLC increased its position in UnitedHealth Group by 7.5% in the fourth quarter. TCM Advisors LLC now owns 1,433 shares of the healthcare conglomerate’s stock worth $725,000 after buying an additional 100 shares during the period. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Trading Up 2.5%

Shares of NYSE UNH opened at $250.74 on Monday. UnitedHealth Group Incorporated has a one year low of $234.60 and a one year high of $630.73. The firm has a market capitalization of $227.46 billion, a PE ratio of 10.86, a PEG ratio of 1.62 and a beta of 0.43. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. The business has a 50-day moving average price of $291.78 and a two-hundred day moving average price of $405.18.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). The firm had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The firm’s quarterly revenue was up 12.9% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $6.80 earnings per share. As a group, analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, June 24th. Investors of record on Monday, June 16th were issued a $2.21 dividend. This is an increase from UnitedHealth Group’s previous quarterly dividend of $2.10. The ex-dividend date was Monday, June 16th. This represents a $8.84 annualized dividend and a yield of 3.5%. UnitedHealth Group’s dividend payout ratio is presently 38.30%.

Wall Street Analysts Forecast Growth

Several equities research analysts have weighed in on UNH shares. Royal Bank Of Canada dropped their target price on UnitedHealth Group from $355.00 to $286.00 and set an “outperform” rating on the stock in a research report on Wednesday, July 30th. Oppenheimer dropped their target price on UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating on the stock in a research report on Wednesday, July 30th. Piper Sandler dropped their target price on UnitedHealth Group from $353.00 to $317.00 and set an “overweight” rating on the stock in a research report on Wednesday, July 30th. Bank of America lowered their price target on UnitedHealth Group from $350.00 to $300.00 and set a “neutral” rating on the stock in a report on Tuesday, July 29th. Finally, Raymond James Financial lowered UnitedHealth Group from a “strong-buy” rating to a “market perform” rating in a report on Wednesday, May 14th. Three equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and fifteen have assigned a buy rating to the company. Based on data from MarketBeat, UnitedHealth Group presently has an average rating of “Hold” and a consensus target price of $366.52.

Insider Transactions at UnitedHealth Group

In related news, CFO John F. Rex bought 17,175 shares of UnitedHealth Group stock in a transaction that occurred on Friday, May 16th. The stock was purchased at an average cost of $291.12 per share, for a total transaction of $4,999,986.00. Following the acquisition, the chief financial officer owned 203,796 shares in the company, valued at $59,329,091.52. This trade represents a 9.20% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Timothy Patrick Flynn bought 1,533 shares of UnitedHealth Group stock in a transaction that occurred on Wednesday, May 14th. The stock was bought at an average price of $320.80 per share, with a total value of $491,786.40. Following the completion of the acquisition, the director owned 6,033 shares in the company, valued at approximately $1,935,386.40. The trade was a 34.07% increase in their position. The disclosure for this purchase can be found here. In the last quarter, insiders acquired 109,408 shares of company stock worth $31,607,768. 0.28% of the stock is currently owned by company insiders.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.